Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Inpatient Dermatology from Horses to Zebras: Lessons Learned at an Academic Hospital

Description

The presentation by Dr. Sergi Rachman discusses cases from the inpatient dermatology service at Northwell Health, a large academic institution. Opening with a review of a 38-year-old male patient experiencing conjunctivitis, ulcers, and rash, Rachman emphasizes the need for urgent evaluation in such scenarios to rule out severe conditions like mucositis. The patient’s slow progression and subsequent worsening led to his hospitalization, where he received treatment including prednisone and topical steroids. Rachman explains the distinguishing features between membranous and pseudomembranous conjunctivitis and potential diagnoses such as reactive infectious mucotaneous eruption (RIME), detailing its clinical characteristics, pathogenesis, and implications for treatment. The second case focuses on a 20-year-old female patient with cutaneous small vessel vasculitis, where the clinical framework for diagnosing vasculitis is outlined, emphasizing careful history-taking and physical examination to determine potential systemic involvement. Rachman's cases illustrate the complexities of diagnosing and managing skin conditions effectively, drawing attention to the psychosocial impact on patients and the importance of multidisciplinary approaches for severe dermatological conditions.

View more

Conclusions

  • Early intervention is crucial for effective management of reactive infectious mucocutaneous eruption (RIME), particularly in patients with mucositis and recent infections.
  • RIME can present with a range of symptoms including ocular involvement, oral ulcers, and cutaneous lesions, making differential diagnosis challenging.
  • A significant portion of RIME cases arise after infections from pathogens like Mycoplasma and COVID-19, warranting consideration in clinical evaluations.
  • Patients presenting with symptoms of vasculitis should undergo thorough laboratory testing and consideration of systemic involvement to avoid complications.
  • Treatment options for RIME generally include corticosteroids and supportive care, and may involve specialized consultations as needed.
  • Granulomatosis with polyangiitis is a serious condition that requires prompt and aggressive treatment, including immunosuppressants and careful management to improve patient outcomes.
  • Understanding the psychosocial impacts of severe mucosal conditions like RIME is important in patient care and follow-up.
  • Li HO, Colantonio S, Ramien ML. Treatment of Mycoplasma pneumoniae-Induced Rash and Mucositis With Cyclosporine. J Cutan Med Surg. 2019 Nov/Dec;23(6):608-612.
  • Mahama A, Kojder P, Thibodeaux Q, Ruth J. Reactive infectious mucocutaneous eruption following COVID-19 in an adolescent boy: Case report and review of the literature. Pediatr Dermatol. 2023 Jan;40(1):162-165.
  • Pan CX, Hussain SH. Recurrent reactive infectious mucocutaneous eruption: A retrospective cohort study. J Am Acad Dermatol. 2023 Aug;89(2):361-364.
  • Rollins PD, Prince AD, Glick M, Biary N. Severe Mycoplasma-Induced Rash and Mucositis Treated With IVIG. Clin Pediatr (Phila). 2020 Oct;59(12):1097-1100.
  • Miller MM, Kamath S, Hughes M, Harter N, Luu M. Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption. JAMA Dermatol. 2021 Feb 1;157(2):230-232.
  • Gimeno E, Morgado-Carrasco D, Moriscot D, Piquero-Casals J. Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient. J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e673-e674. doi: 10.1111/jdv.18213.
  • Liakos W, Xu A, Finelt N. Clinical features of recurrent Mycoplasma pneumoniae-induced rash and mucositis. Pediatr Dermatol. 2021 Jan;38(1):154-158.
  • Gantous A, Fernández-Pellon Garcia RF. Nasal Reconstruction in Granulomatosis with Polyangiitis: A Two Decade Review. Facial Plast Surg Aesthet Med. 2023 Jan-Feb;25(1):61-67.
  • Wetter DA, Dutz JP, Shinkai K, Fox LP. Cutaneous vasculitis. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology, 4th ed. Philadelphia, PA: Elsevier;2017:409-439.
  • Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021.